NORTHERN TRUST CORP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$35,373
+31.6%
168,0400.0%0.00%
Q1 2023$26,886
-71.3%
168,040
-0.5%
0.00%
Q4 2022$93,768
-53.3%
168,9500.0%0.00%
Q3 2022$201,000
+89.6%
168,950
+0.3%
0.00%
Q2 2022$106,000
-88.0%
168,380
-78.4%
0.00%
Q1 2022$887,000
-51.5%
778,185
-4.3%
0.00%
Q4 2021$1,830,000
-42.7%
813,561
-12.9%
0.00%
-100.0%
Q3 2021$3,192,000
+8.7%
933,537
-4.9%
0.00%0.0%
Q2 2021$2,936,000
+328.0%
981,609
+362.1%
0.00%
Q1 2021$686,000
+104.2%
212,402
+34.0%
0.00%
Q4 2020$336,000
+72.3%
158,523
-4.7%
0.00%
Q3 2020$195,000
+28.3%
166,362
-1.2%
0.00%
Q2 2020$152,000
+4.1%
168,305
-3.2%
0.00%
Q1 2020$146,000
-12.6%
173,903
-0.2%
0.00%
Q4 2019$167,000
-7.7%
174,238
-0.7%
0.00%
Q3 2019$181,000
-42.9%
175,436
-0.4%
0.00%
Q2 2019$317,000
-0.9%
176,173
+3.7%
0.00%
Q1 2019$320,000
+59.2%
169,847
-0.1%
0.00%
Q4 2018$201,000
-57.4%
169,965
-2.4%
0.00%
Q3 2018$472,000
+39.2%
174,057
-1.8%
0.00%
Q2 2018$339,000
-4.0%
177,194
+5.5%
0.00%
Q1 2018$353,000
+5.7%
167,990
+2.0%
0.00%
Q4 2017$334,000
-33.9%
164,687
-56.6%
0.00%
Q3 2017$505,000
-14.8%
379,443
+0.4%
0.00%
Q2 2017$593,000
-75.8%
378,071
-50.2%
0.00%
-100.0%
Q1 2017$2,454,000
+137.1%
759,909
-0.8%
0.00%
Q4 2016$1,035,000
-13.9%
766,282
-0.6%
0.00%
Q3 2016$1,202,000
+27.2%
770,632
+8.5%
0.00%
Q2 2016$945,000
-70.2%
710,320
+18.3%
0.00%
-100.0%
Q1 2016$3,174,000
-32.0%
600,475
+1.0%
0.00%
-50.0%
Q4 2015$4,665,000
-4.6%
594,257
+2.6%
0.00%0.0%
Q3 2015$4,892,000
-19.3%
579,044
+4.6%
0.00%0.0%
Q2 2015$6,062,000
-19.7%
553,654
+2.5%
0.00%0.0%
Q1 2015$7,551,000
-16.4%
540,193
+1.0%
0.00%
-33.3%
Q4 2014$9,035,000
+24.3%
534,958
-1.2%
0.00%
+50.0%
Q3 2014$7,266,000
+0.3%
541,481
-4.8%
0.00%0.0%
Q2 2014$7,245,000
+0.1%
568,673
-6.6%
0.00%0.0%
Q1 2014$7,239,000
-21.3%
608,817
-8.6%
0.00%
-33.3%
Q4 2013$9,203,000
-19.1%
666,348
+2.2%
0.00%
-25.0%
Q3 2013$11,369,000
+37.2%
652,285
+27.4%
0.00%
+33.3%
Q2 2013$8,287,000511,8250.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders